Literature DB >> 8981953

Predisposition to the fragile X syndrome in Jews of Tunisian descent is due to the absence of AGG interruptions on a rare Mediterranean haplotype.

T C Falik-Zaccai1, E Shachak, M Yalon, Z Lis, Z Borochowitz, J N Macpherson, D L Nelson, E E Eichler.   

Abstract

We have studied the ethnic distribution of the fragile X syndrome in Israel and have found that 36/136 (26.5%) of apparently unrelated pedigrees were of Tunisian Jewish descent. The Tunisian Jews, however, constitute only 2%-3% of the general Israeli population, identifying the first ethnic group significantly (P < .001) predisposed to the development of this disease. Associated with this increase in disease prevalence, we have found an unusually high incidence of FMR1 CGG repeats devoid of AGG interruptions among the normal Tunisian Jewish population (30/150, or 20.0%). Furthermore, the proportion of these alleles beyond the FMR1 CGG repeat instability threshold (>35 repeats) (8/150, or 5.3%) was significantly greater (P < .04) than that proportion found among non-Tunisian Jewish controls in Israel (1/136). Haplotype analysis has indicated that these large uninterrupted CGG repeat alleles are present on a previously unreported (DXS548-FRAXAC1-FRAXAC2) haplotype that accounts for all observed cases of disease among Tunisian Jewish X chromosomes. The high prevalence of disease among Tunisian Jews, we suggest, is due to a founder effect of this rare haplotype, which is completely devoid of AGG interruptions in the Jewish population of Tunisia.

Entities:  

Mesh:

Year:  1997        PMID: 8981953      PMCID: PMC1712540     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  38 in total

1.  Fragile-X syndrome in Hawaii: a summary of clinical experience.

Authors:  F A Rhoads
Journal:  Am J Med Genet       Date:  1984-01

2.  Insert size and flanking haplotype in fragile X and normal populations: possible multiple origins for the fragile X mutation.

Authors:  J N Macpherson; H Bullman; S A Youings; P A Jacobs
Journal:  Hum Mol Genet       Date:  1994-03       Impact factor: 6.150

3.  X-linked mental retardation, macro-orchidism, and the Xq27 fragile site.

Authors:  G Turner; A Daniel; M Frost
Journal:  J Pediatr       Date:  1980-05       Impact factor: 4.406

4.  No marker (X) syndrome in autistic children.

Authors:  P A Venter; J Op't Hof; D J Coetzee; C Van der Walt; A E Retief
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

5.  A community study of severe mental retardation in the West Midlands and the importance of the fragile X chromosome in its aetiology.

Authors:  S Bundey; T P Webb; A Thake; J Todd
Journal:  J Med Genet       Date:  1985-08       Impact factor: 6.318

6.  Strong founder effect for the fragile X syndrome in Sweden.

Authors:  H Malmgren; K H Gustavson; C Oudet; G Holmgren; U Pettersson; N Dahl
Journal:  Eur J Hum Genet       Date:  1994       Impact factor: 4.246

7.  Haplotype analysis at the FRAXA locus in the Japanese population.

Authors:  R I Richards; I Kondo; K Holman; M Yamauchi; N Seki; K Kishi; A Staples; G R Sutherland; T Hori
Journal:  Am J Med Genet       Date:  1994-07-15

8.  Fragile X founder chromosome effects: linkage disequilibrium or microsatellite heterogeneity?

Authors:  N Zhong; L Ye; C Dobkin; W T Brown
Journal:  Am J Med Genet       Date:  1994-07-15

9.  Cryptic and polar variation of the fragile X repeat could result in predisposing normal alleles.

Authors:  C B Kunst; S T Warren
Journal:  Cell       Date:  1994-06-17       Impact factor: 41.582

10.  The fragile (X) syndrome: the mutation problem.

Authors:  P A Jacobs; S Sherman; G Turner; T Webb
Journal:  Am J Med Genet       Date:  1986 Jan-Feb
View more
  23 in total

1.  FMR1 haplotype analyses among Indians: a weak founder effect and other findings.

Authors:  Deepti Sharma; Meena Gupta; B K Thelma
Journal:  Hum Genet       Date:  2002-12-14       Impact factor: 4.132

2.  FMR1 CGG Repeats: Reference Levels and Race-Ethnic Variation in Women With Normal Fertility (Study of Women's Health Across the Nation).

Authors:  Lisa M Pastore; Ani Manichaikul; Xin Q Wang; Joel S Finkelstein
Journal:  Reprod Sci       Date:  2016-02-22       Impact factor: 3.060

Review 3.  Fragile sites-cytogenetic similarity with molecular diversity.

Authors:  G R Sutherland; R I Richards
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

4.  Evolution of the Friedreich's ataxia trinucleotide repeat expansion: founder effect and premutations.

Authors:  M Cossée; M Schmitt; V Campuzano; L Reutenauer; C Moutou; J L Mandel; M Koenig
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

5.  Genetic diversity of the fragile X syndrome gene (FMR1) in a large Sub-Saharan West African population.

Authors:  Emmanuel K Peprah; Emily G Allen; Scott M Williams; Laresa M Woodard; Stephanie L Sherman
Journal:  Ann Hum Genet       Date:  2010-07       Impact factor: 1.670

6.  Improved Assays for AGG Interruptions in Fragile X Premutation Carriers.

Authors:  Bruce E Hayward; Karen Usdin
Journal:  J Mol Diagn       Date:  2017-08-14       Impact factor: 5.568

7.  Paternally transmitted FMR1 alleles are less stable than maternally transmitted alleles in the common and intermediate size range.

Authors:  Amy K Sullivan; Dana C Crawford; Elizabeth H Scott; Mary L Leslie; Stephanie L Sherman
Journal:  Am J Hum Genet       Date:  2002-05-03       Impact factor: 11.025

8.  Distribution of AGG interruption patterns within nine world populations.

Authors:  Carolyn M Yrigollen; Stefan Sweha; Blythe Durbin-Johnson; Lili Zhou; Elizabeth Berry-Kravis; Isabel Fernandez-Carvajal; Sultana Mh Faradz; Khaled Amiri; Huda Shaheen; Roberta Polli; Luis Murillo-Bonilla; Gabriel de Jesus Silva Arevalo; Patricia Cogram; Alessandra Murgia; Flora Tassone
Journal:  Intractable Rare Dis Res       Date:  2014-11

9.  Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel.

Authors:  H Toledano-Alhadef; L Basel-Vanagaite; N Magal; B Davidov; S Ehrlich; V Drasinover; E Taub; G J Halpern; N Ginott; M Shohat
Journal:  Am J Hum Genet       Date:  2001-07-06       Impact factor: 11.025

10.  The economic burden of fragile x syndrome: healthcare resource utilization in the United States.

Authors:  Patricia Sacco; Gorana Capkun-Niggli; Xin Zhang; Rosemary Jose
Journal:  Am Health Drug Benefits       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.